ARTICLE | Clinical News
Sangamo preclinical data
September 24, 2007 7:00 AM UTC
SGMO's CCR5 co-receptor modifying zinc finger nucleases (CCR5-ZFN) conferred HIV resistance to CD4 T cells in vitro. In mice, CD4 T cells modified by CCR5-ZFN preferentially survived and expanded fol...